Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
FasterCures recently hosted a congressional briefing, during which more than 100 congressional staffers, patient advocates, academics, and drug developers came together to hear about the importance of federally supported translational research.
PATH and Standard Diagnostics, Inc., have formed an agreement to bring to market a rapid test for the neglected tropical disease onchocerciasis, also known as river blindness.
For the first time, an international team of researchers has estimated that after an initial dengue infection, a person is protected from infection with other strains for between one and three years. The results have implications for designing more effective dengue vaccine studies.
Recent breakthroughs in HIV prevention research and development have confirmed the promise of new options to help end the AIDS epidemic and highlight the urgent need for ongoing research to develop additional prevention options, according to a new report from the HIV Vaccines and Microbicides Resource Tracking Working Group.
Health advocates are saying that a free trade pact under negotiation between the United States and 11 Asia-Pacific nations will impose intellectual property rules that could restrict access to affordable medicines in developing countries.